Methods and systems for visualization of endotoxins in fluid samples
The real-time monitoring of endotoxin reactions through the graphical user interface and porous microplate sensor system solves the problems of existing endotoxin testing complexity and difficulty in data presentation, improves testing efficiency and accuracy, and simplifies abnormal recognition.
Patent Information
- Application Number
- CN202080018922.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-03-29
- Filing Date
- 2020-03-09
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2040-03-09
AI Technical Summary
The existing endotoxin testing methods are complex, time-consuming and error-prone, and lack a system that facilitates data presentation, resulting in low testing efficiency and many errors, making it difficult to distinguish between test abnormalities and sample abnormalities.
A system composed of processor and memory is used to display the measurement results of endotoxin concentration through a graphical user interface, and the endotoxin reaction is monitored and visualized in real time using porous microplate and sensor systems to provide kinetic curves and reaction progress graphs, simplifying data presentation and analysis .
It improves the efficiency and accuracy of endotoxin testing, reduces operational steps and artificial errors, provides intuitive data visualization, and simplifies the abnormal identification and analysis process.
Smart Images

Figure CN114026425B_ABST
Abstract
Description
[0001] Related Applications
[0002] This PCT application claims priority to and the benefit of U.S. Provisional Patent Application No. 62 / 815,716, filed on March 8, 2019, entitled “Method and System for Visualization of Endotoxins in a Fluid sample,” U.S. Provisional Patent Application No. 62 / 826,253, filed on March 29, 2019, entitled “Method and System for Visualization of Endotoxins in a Fluid sample,” and U.S. Provisional Patent Application No. 62 / 826,355, filed on March 29, 2019, entitled “Method and System for Visualization of Endotoxins in a Fluid sample,” each of which is incorporated herein by reference in its entirety.
[0003] background
[0004] Microbial contamination (e.g., Gram-positive bacteria, Gram-negative bacteria, yeasts, and fungi) can cause severe illness and even death in humans. When a person is infected with Gram-negative bacteria, the bacteria may produce pyrogenic bacterial endotoxins. Endotoxins can be dangerous and even fatal to humans. Endotoxin molecules are lipopolysaccharide components of the cell walls of Gram-negative bacteria that can be present in the surfaces of pharmaceutical preparations and medical devices, regardless of microbial contamination. Endotoxin contamination may occur even if the system passes sterility testing, which is why independent endotoxin testing is also required.
[0005] At present, multiple tests are developed to detect the presence of endotoxins in or on the sample being tested using hemocyte lysates from horseshoe crabs. When hemocyte lysates are exposed to endotoxins, coagulation will occur. Hemocyte lysates are amebocyte lysates produced from the hemolymph of various horseshoe crabs (including horseshoe crabs (Limulus), horseshoe crabs (Tachypleus) and scorpion genus). Commonly used amebocyte lysates are produced from the hemolymph of horseshoe crabs or horseshoe crabs, and are referred to as horseshoe crab amebocyte lysates ("LAL"). Routine tests using LAL include gel clot test, endpoint turbidity analysis test, kinetic turbidity analysis test, endpoint chromogenic test and kinetic chromogenic test. Tests using LAL can also be used to test specific types of glucans, markers for fungal contamination.
[0006] More information about the LAL test and the standards used can be found in the United States Pharmacopeia ("USP") Chapter 85 "Bacterial Endotoxins Test" ("BET"), Japanese Pharmacopeia 4.01 "Bacterial Endotoxin Test", European Pharmacopoeia 2.6.14 "Bacterial Endotoxins" and other equivalent national pharmacopeias. Supplementary information to the internationally harmonized pharmacopoeias can be found in ICH Q4B Annex 14 "Bacterial Endotoxin Test General Chapter". For endotoxin testing in medical devices, information can be found in USP Chapter 161 "Transfusion and Infusion Assemblies and Similar Medical Devices" and ANSI / AAMI ST72 "Bacterial endotoxins—Test methods, routine monitoring, and alternatives to batch testing". These standards and procedures may be generally referred to as compendia.
[0007] Manufacturers of pharmaceutical, medical equipment and food industries must meet specific standards to ensure that their products do not contain microorganisms or endotoxin contamination. These industries need to test the presence of endotoxins frequently, accurately and sensitively to meet various safety standards, such as the standards set by the U.S. Food and Drug Administration or the Environmental Protection Agency. These agencies accept many pharmacopoeia procedure standards. Therefore, if manufacturers want to obtain government approval to release new products to the market, when products meet the methods and standards in the pharmacopoeia listed above, many of the FDA requirements may also be met. This can greatly reduce the cost of FDA approval for manufacturers to obtain new products.
[0008] These agencies also have strict reporting requirements when test results show bad results or endotoxin concentrations outside the expected range. Such non-compliant results must be thoroughly investigated to find the root cause and explained to the regulatory agency. This is time-consuming and expensive. If the manufacturer can prove that the non-compliant result occurred due to an anomaly in the test itself and not due to the presence of endotoxin actually in or on the sample, then many of the reporting requirements for the agency may be met. This may reduce the time and cost incurred in fulfilling such reporting obligations. To date, there is no known method or device that can distinguish between an anomaly or error in the test itself and an anomaly in the sample.
[0009] In various pharmacopeias, these tests require the inclusion of an aqueous solution containing a known endotoxin concentration for use as a standard. These aqueous solutions are generally unstable; therefore, they are usually made from powdered toxin at the testing site just prior to testing. The LAL reagent also usually comes in powder form and must be reconstituted in an aqueous solution before use.
[0010] Preparation of endotoxin and LAL powders is difficult due to the slow solvation of key biomolecules and their tendency to stick to surfaces during mixing and then coagulate on the surface. The LAL reagent also begins to react slowly upon reconstitution and has a very short shelf life. While best practice is to mix these immediately before use, workflows generally dictate that they be mixed at the beginning of the process. Moreover, the preparation process is susceptible to contamination by endotoxins that are ubiquitous in the environment.
[0011] Institutions also require a series of calibration tests to ensure that the equipment and reagents used are functioning correctly. Calibration tests and sample measurements must also be performed more than once. Current laboratory methods that comply with BET and other pharmacopeias are very detailed and require repeated and highly accurate measurements of the volume of fluid to be dispensed into multiple inlets of a microplate or the like without contamination.
[0012] The most common method of performing LAL analysis is to use a microwell plate and reader. A matrix of reaction wells open at the top and with transparent windows on the bottom is placed in a heated spectrophotometric reader for multiple simultaneous experiments. There are many disadvantages, including the long time it takes to prepare the plates, its high cost, the opportunity for error and contamination, and the need for specially trained and assigned technicians for this task to complete the job.
[0013] Highly skilled operators are constantly monitored to ensure proper technique and accuracy of measurements and tests, and operators are retrained as needed to ensure accuracy of repetitive actions. A typical method may have up to 248 slow and time-consuming pipetting steps, making the method error-prone due to its complexity and susceptible to contamination due to its length and number of manipulations.
[0014] Methods and devices are developed to reduce the number of steps in endotoxin testing or to automate some or all of the steps. Some methods include automating one or more pipetting or aliquoting steps, automatic mixing of samples, or preloading reagents in test substrates that only allow a very limited number of tests. However, all developed methods or devices lack one or more of the following aspects: low-cost automation designed into the substrate, disposable clean substrates to ensure cleanliness, pharmacopoeia test compliance on each substrate, built-in individual test measurement verification, and simplicity of measurement operation.
[0015] Other microfluidic approaches exist to partially automate the testing process, but these are not fully compatible with compendial methods due to their limited size and their reliance on stored calibrations rather than calibrations run at the same time in the same device using the same reagents and standards. It also requires precise sample measurement; no aliquots are generated by the instrument or device itself.
[0016] Other automated methods rely on robots to measure and dispense samples and reagents in microplates. Once prepared, the plates can be loaded into the reader manually or using another robot. The robot is usually a pipette-based dispensing system that accurately transfers samples and reagents from vial racks to the plates, replacing pipette tips to prevent cross contamination.
[0017] This is an expensive system that requires frequent validation of its robotic operation and multiple disposables (pipette tips, multi-wall plates, dilution tubes, pipette filling trays, sampling bottles, etc.) for each run. It also prepares wells sequentially, and as with manual preparation, all reactions cannot be started at the same time. Contamination remains a problem, and because the process is generally not monitored, there is no legal way to reject contaminated samples on statutory grounds.
[0018] Automated systems based on flow injection or sequential injection have also been developed. They use disposable microfluidics that do not require cleaning and are not susceptible to contamination. This is a considerable improvement because it performs the analysis simultaneously and is therefore faster and in accordance with pharmacopoeia regulations.
[0019] To date, however, there are no known methods or systems that facilitate the presentation of data resulting from testing and analyzing endotoxin concentrations in fluid samples.
[0020] Improved visualization of test progress for endotoxin testing is also of benefit.
[0021] Overview
[0022] The illustrated methods and systems facilitate presentation of data obtained from measurements of endotoxins in a fluid sample. In particular, the illustrated methods and systems facilitate presentation of such measurements in a graphical user interface and / or in a report for endotoxin concentrations in a fluid sample. The presentation facilitates unified and intuitive graphical visualization presented in a single interactive interface and / or report.
[0023] In some embodiments, a system for testing for endotoxins in an injectable drug product or water is disclosed. The system includes a processor and a memory having instructions stored thereon, wherein execution of the instructions by the processor causes the processor to continuously obtain one or more data sets associated with measurements of the multi-well microplate during acquisition of measurements of the multi-well microplate, wherein each measurement is associated with i) endotoxin in the acquired sample of the injectable drug product or water over time and ii) a measured level (e.g., associated changes in optical properties (e.g., absorbance, brightness, and / or fluorescence, etc.) of an endotoxin reaction of one or more test reagents (e.g., where the injectable drug product or water includes one or more reagents mixed with a drug or mixed with a test drug or water sample), wherein the data set includes a current measured level of endotoxin reaction for each well of the multi-well microplate, wherein the multi-well microplate includes at least 96 wells. The instructions, when executed by the processor, cause the processor to display a side-by-side graphic comprising a plurality of visual elements in a pane of a graphical user interface based on the acquired data set, wherein each of the plurality of visual elements is associated with a current measured level of each of at least 96 wells of a multi-well microplate, wherein each of the plurality of visual elements comprises a vertically oriented bar configured to display a data value spanning a range between a minimum value and a maximum value, wherein each of the minimum value and the maximum value is aligned with a corresponding first horizontal line and a second horizontal line. The display also includes a visual element comprising a third horizontal line at a value indicating a starting threshold of an endotoxin reaction for each of at least 96 wells of the multi-well microplate or among the well groups. The side-by-side graphic of at least 96 wells of the multi-well microplate provides a simultaneous comparison of the progress of an endotoxin reaction in at least 96 wells of the multi-well microplate or among the well groups to test for endotoxin in an acquired sample of an injectable drug product or water.
[0024] In one aspect, a computer-implemented method for formatting a display (e.g., a graphical user interface or report) to present a visualization of endotoxin concentration in a fluid sample is disclosed, the method comprising generating, by a processor, a graphical visualization for a graphical user interface or report to be displayed on a fixed or mobile computing device based on a data set identifying optical density (OD) readings of a microplate comprising a plurality of optical wells, each optical well containing a fluid sample, the graphical visualization comprising a vertically-oriented bar graph having a plurality of vertical bars, at least one vertically-oriented bar graph for each optical well of the microplate, wherein, as a reaction between horseshoe crab amebocyte lysate (LAL) and bacterial endotoxin occurs in the optical wells of the microplate, the processor causes the vertically-oriented bar graphs corresponding to the optical wells of the microplate to increase vertically over time, wherein the greater the amount of endotoxin present in the optical well (whether associated with a sample, an endotoxin standard, or a positive product control), the faster the reaction with the LAL reagent occurs, and subsequently the processor causes the associated vertically-oriented bar graph to increase faster on the graphical visualization.
[0025] In some embodiments, the method also includes generating, by the processor, a horizontal line representing a threshold OD or a starting OD on a graphical visualization, wherein the time when the vertically oriented bar graph corresponding to the optical hole reaches or crosses the horizontal line is referred to as the "start time" or "reaction time" of the fluid sample in the optical hole corresponding to the vertically oriented bar graph reaching or crossing the horizontal line.
[0026] In some embodiments, the processor causes the color of the vertically-oriented bar graph to change from a first color to a second color once the vertically-oriented bar graph reaches the horizontal line.
[0027] In some embodiments, the first color is blue and the second color is green.
[0028] In some embodiments, the method further comprises generating, by the processor, a vertically oriented bar graph representing the endotoxin standards and the negative control, the vertically oriented bar graph also displayed on the graphical visualization.
[0029] In some embodiments, vertically oriented bars representing endotoxin standards are marked by the processor with a first color, vertically oriented bars representing negative controls are marked by the processor with a second color, and vertically oriented bars corresponding to optical wells of the microplate are marked by the processor with a third color.
[0030] In some embodiments, vertically oriented bars representing endotoxin standards are marked by the processor in a darker green color, vertically oriented bars representing negative controls are marked by the processor in red, and vertically oriented bars corresponding to optical wells of the microplate are marked by the processor in blue.
[0031] In some embodiments, vertically oriented bars representing endotoxin standards are marked by the processor with a darker green, vertically oriented bars representing negative controls are marked by the processor with red, and vertically oriented bars corresponding to optical wells of the microplate are marked by the processor with a lighter green.
[0032] In some embodiments, the vertically oriented bar graph representing the endotoxin standard is marked by the processor with a darker green color, the vertically oriented bar graph representing the negative control is marked by the processor with red color, and the vertically oriented bar graph corresponding to the optical wells of the microplate is marked by the processor with blue color, until the vertically oriented bar graph corresponding to the optical wells of the microplate reaches a horizontal line representing a threshold OD or a starting OD generated by the processor on a graphical visualization, at which time the vertically oriented bar graph corresponding to the optical wells of the microplate is turned green by the processor.
[0033] In some embodiments, the method further comprises generating, by the processor, on the graphical visualization, a vertically oriented bar graph representing the positive product control.
[0034] In some embodiments, once the vertically oriented bar graph corresponding to the optical wells of the microplate reaches a horizontal line generated by the processor on a graphical visualization, the vertically oriented bar graph representing the positive product control is marked by the processor using the same color that is used by the processor to mark the vertically oriented bar graph corresponding to the optical wells of the microplate, where the horizontal line represents a threshold OD or a starting OD.
[0035] In some embodiments, the vertically oriented bar graph representing a positive product control is marked by the processor using a green color.
[0036] In some embodiments, the positive product control is calculated by the processor according to the following formula: (endotoxin concentration in PPC - endotoxin concentration in sample) ÷ actual endotoxin concentration of the 0.5 EU / mL standard.
[0037] In another aspect, a system is disclosed that can perform any of the above methods.
[0038] In another aspect, a non-transitory computer-readable medium comprising computer-executable instructions is disclosed, wherein when executed, the computer-executable instructions cause a processor to perform any of the above methods.
[0039] In another aspect, a report (eg, a non-transitory report) generated according to the above method is disclosed.
[0040] In another aspect, a system for testing for endotoxins in an injectable drug product or water is disclosed, the system comprising: a processor; and a memory having instructions stored thereon, wherein execution of the instructions by the processor causes the processor to continuously obtain one or more data sets associated with measurements of the multiwell microplate during acquisition of measurements of the multiwell microplate, wherein each measurement is associated with i) endotoxin in an acquired sample of the injectable drug product or water over time and ii) a measured level (e.g., associated changes in optical properties (e.g., absorbance, brightness, and / or fluorescence, etc.) of an endotoxin reaction of one or more test reagents (e.g., where the injectable drug product or water includes one or more reagents mixed with a drug or with a test drug or water sample), and wherein the data set includes a current measured level of endotoxin reaction for each well of the multiwell microplate, wherein the multiwell microplate includes at least 96 wells; and displaying a side-by-side graphic including a plurality of visual elements exclusively in a pane of a graphical user interface based on the acquired data set, wherein each of the plurality of visual elements is associated with a current measured level for each of at least 96 wells of a multi-well microplate, wherein each of the plurality of visual elements includes a vertically oriented bar configured to display data values spanning a range between a minimum value and a maximum value, wherein each of the minimum value and the maximum value is aligned with a corresponding first horizontal line and a second horizontal line, wherein the display further includes a visual element including a third horizontal line at a value indicating a starting threshold of an endotoxin reaction for each of the at least 96 wells or groups of wells of the multi-well microplate, and wherein the side-by-side graphic of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the progression of the endotoxin reaction in the at least 96 wells or groups of wells of the multi-well microplate to test for endotoxin in an acquired sample of an injectable drug product or water.
[0041] In some embodiments, a side-by-side graphic of at least 96 wells of a multi-well microplate provides an indication of incorrectly configured wells, and wherein the indication is used to retest samples of injectable drug product or water or evaluate samples in the incorrectly configured wells in subsequent testing.
[0042] In some embodiments, one or more data sets associated with measurements of a multi-well microplate having at least 96 wells are continuously acquired and displayed at predetermined intervals of at least once a second (e.g., every 5 seconds), wherein the interval is fixed to provide an observation of the rate of endotoxin reaction in at least 96 wells or a portion of the 96 wells.
[0043] In some embodiments, the instructions, when executed by a processor, cause the processor to receive input from an input device, wherein the input is associated with a displayed cursor; determine, in a pane of a graphical user interface, that the cursor is placed over one of a plurality of visual elements for at least one selection from a group consisting of selections of visual elements (e.g., by a mouse click or by a keyboard click) or (e.g., by a hovering action) for a predetermined period of time; and display, in the pane or a second pane of the graphical user interface: i) a graph of measured levels of endotoxin response over time for one or more wells where the cursor is placed, or ii) a measured parameter associated with the one or more wells where the cursor is placed.
[0044] In some embodiments, a graph of measured levels of endotoxin response over time is presented, and wherein the graph includes one or more kinetic curves for selected wells over a reaction time.
[0045] In some embodiments, the system further comprises a display having greater than twice the number of horizontal pixel elements of the multi-well microplate (eg, to provide a bar having a pixel width greater than 2).
[0046] In some embodiments, the display has a set of vertical pixel elements, and wherein each visual element of the plurality of visual elements spans at least 80% of the set of vertical pixel elements.
[0047] In some embodiments, a portion of at least 96 wells of a multi-well microplate includes a set of one or more standard wells, the set of one or more standard wells including a first standard well and a second standard well, wherein the visual elements associated with the first well and the second well have a different color than the remaining portion of the at least 96 wells of the multi-well microplate.
[0048] In some embodiments, the method further includes a sensor system configured to interrogate at least 96 wells of the multiwell microplate for measurements of the measured level of endotoxin response in the multiwell microplate, wherein the sensor system includes one or more sensors selected from the group consisting of an absorbance sensor, a fluorescence sensor, and a luminescence sensor.
[0049] In some embodiments, the sensor system is configured as a 96-well microplate.
[0050] In some embodiments, the sensor system is configured as a 104-well microplate.
[0051] In some embodiments, the measured level of endotoxin reaction comprises a value associated with a measured change in clarity of the obtained sample of the injectable drug product or water associated with a reaction with one or more test agents.
[0052] In some embodiments, the measured level comprises a value associated with a measured change in an optical property of the acquired sample of the injectable drug product or water associated with a reaction with one or more test agents, the optical property selected from the group consisting of absorbance, brightness, fluorescence, and combinations thereof.
[0053] In some embodiments, the plurality of visual elements include a first group of visual elements associated with the standard wells, a second group of visual elements associated with the standard wells, a third group of visual elements associated with the standard wells, a fourth group of visual elements associated with the standard wells, a fifth group of visual elements associated with the standard wells, and a sixth group of visual elements associated with the standard wells, wherein the first group of visual elements has a 50-EU / ml standard, wherein the second group of visual elements has a 5-EU / ml standard, wherein the third group of visual elements has a 0.5-EU / ml standard, wherein the fourth group of visual elements has a 0.05-EU / ml standard, wherein the fifth group of visual elements has a 0.005-EU / ml standard, and wherein the sixth group of visual elements has a negative control standard.
[0054] In some embodiments, the value indicating the starting threshold is user selectable.
[0055] In some embodiments, the instructions, when executed by a processor, cause the processor to receive input from an input device (e.g., a mouse click on a GUI element, a shortcut key on a keyboard, etc.), wherein the input is associated with a selection of a measurement parameter of a multi-well microplate, the measurement parameter being selected from the group consisting of: a measured start time, a measured endotoxin concentration, a measured positive product control (PPC) recovery, and a determined matrix effect; obtain one or more second data sets associated with the selected parameters; and display a second plurality of visual elements associated with the selected parameters in a pane or a second pane of the graphical user interface, wherein the second plurality of visual elements has a number corresponding to at least 96 wells or a portion of the at least 96 wells.
[0056] In another aspect, a method of monitoring testing for endotoxins in an injectable pharmaceutical product or water is disclosed, the method comprising obtaining, by a processor, one or more data sets associated with measurement results of a multi-well microplate, wherein each measurement result is associated with a measured level of endotoxin in a sample obtained of the injectable pharmaceutical product or water over time, wherein the data set comprises a current measured level for each well of the multi-well microplate, wherein the multi-well microplate comprises at least 96 wells; and displaying, by the processor, in a pane of a graphical user interface, a side-by-side graphic comprising a plurality of visual elements exclusively based on the obtained data set, wherein each of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate. The display is associated with a current measured level of each of the at least 96 wells of the multi-well microplate, wherein each of the plurality of visual elements comprises a vertically oriented bar configured to span data values ranging between a minimum value and a maximum value, wherein each of the minimum value and the maximum value coincides with a first horizontal line and a second horizontal line, wherein the display further comprises a visual element comprising a third horizontal line at a measured value indicating a starting threshold for each of the at least 96 wells of the multi-well microplate, and wherein a side-by-side graphic of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the speed of reactions in the at least 96 wells or groups of wells of the multi-well microplate to monitor testing for endotoxins in acquired samples of injectable drug products or water.
[0057] In some embodiments, the method further comprises interrogating at least 96 wells of the multiwell microplate for acquisition of the measured level of endotoxin response in the multiwell microplate, wherein the sensor system comprises one or more sensors selected from the group consisting of absorbance sensors, fluorescence sensors, and luminescence sensors.
[0058] In another aspect, a non-transitory computer-readable medium is disclosed having instructions stored thereon, wherein execution of the instructions by a processor causes the processor to obtain one or more data sets associated with measurements of a multi-well microplate, wherein each measurement is associated with a measured level of endotoxin in a sample taken of an injectable drug product or water over time, wherein the data sets include a current measured level for each well of the multi-well microplate, wherein the multi-well microplate includes at least 96 wells; and display a side-by-side graphic including a plurality of visual elements exclusively in accordance with the obtained data sets in a pane of a graphical user interface, wherein each of the plurality of visual elements is associated with at least 96 wells of the multi-well microplate. The display is configured to be associated with a current measured level for each of the at least 96 wells of the multi-well microplate, wherein each of the plurality of visual elements comprises a vertically oriented bar configured to span a range of data values between a minimum value and a maximum value, wherein each of the minimum value and the maximum value coincides with a first horizontal line and a second horizontal line, wherein the display further comprises a visual element comprising a third horizontal line at a measured value indicating a starting threshold for each of the at least 96 wells of the multi-well microplate, and wherein the side-by-side graphic of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the rates of reactions in the at least 96 wells or groups of wells of the multi-well microplate to monitor testing for endotoxins in an acquired sample of an injectable drug product or water.
[0059] In some embodiments, the instructions, when executed by the processor, further cause the processor to control a sensor system configured to interrogate and acquire measurement results of at least 96 wells of a multi-well microplate for measurement results of a measured level of an endotoxin reaction in the multi-well microplate, wherein the sensor system comprises one or more sensors selected from the group consisting of an absorbance sensor, a fluorescence sensor, and a cold light sensor.
[0060] Other systems, methods, features and advantages will or may become apparent to those skilled in the art upon examination of the following drawings and detailed description. All such additional systems, methods, features and / or advantages are deemed to be included in this description and protected by any accompanying claims in this application or any application claiming priority to this application. BRIEF DESCRIPTION OF THE DRAWINGS
[0062] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments and, together with the description, are used to explain the principles of the methods and systems. The components in the drawings are not necessarily to scale relative to each other. Like reference numerals designate corresponding parts throughout the several views. The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawings will be provided by the Office upon request and payment of the necessary fee:
[0063] Figure 1 is a block diagram of an exemplary system for analyzing a fluid sample for endotoxins;
[0064] Figures 2A-2K is a screen shot of an exemplary graphical user interface (GUI) of an embodiment of the analysis software described herein;
[0065] Figure 3A and Figure 3B each showing a graphical user interface including a visual representation in the form of a vertically oriented bar graph of a kinetic reaction that occurs when an endotoxin analysis is performed using the analysis software described herein;
[0066] Figure 4A , Figure 4B and Figure 4C All show how reaction rates, the progress of reactions, and the relative progress of reactions can be viewed from instant visualization according to illustrative embodiments;
[0067] Figure 5A and Figure 5B is an example of a commercially available visualization of a LAL test in a 96-well microplate;
[0068] Fig. 6A Shown is a time series kinetic response graph of a 104-well microplate arranged to provide a more intuitive review of the assessment of the progress of the LAL test. Figure 6B and Figure 6C The same situation is shown at different levels of viewing ratio;
[0069] Figure 7 , Figure 8 , Fig. 9 , Fig.10 , Fig.11 , Fig.12 , Fig.13 each showing example views of example parameters of wells or groups of wells in a microplate that may be displayed in a side-by-side vertical orientation according to one embodiment; and
[0070] Fig.14 An exemplary computer with a processor that can be used to execute the analysis software described herein is shown.
[0071] Detailed Description
[0072] Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Methods and materials similar or equivalent to those described herein may be used in the practice or testing of the present disclosure. As used in the specification and in the claims, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise. As used herein, the term "comprising" and its variants are used synonymously with the term "including" and its variants and are open, non-limiting terms. The word "comprise" and variants of the word such as "comprising" and "comprises" mean "including but not limited to", and are not intended to exclude, for example, other additives, ingredients, wholes or steps. "Exemplary" means "example", and is not intended to convey an indication of a preferred or ideal embodiment. "For example" is not used in a limiting sense but for the purpose of explanation. As used herein, the terms “optional” or “optionally” mean that the subsequently described feature, event or circumstance may or may not occur, and that the description includes instances where the feature, event or circumstance occurs and instances where it does not.
[0073] Before the current method and system are disclosed and described, it should be understood that the method and system are not limited to specific synthetic methods, specific components or specific compositions. It should also be understood that the terminology used herein is only for the purpose of describing specific embodiments and is not intended to be limiting.
[0074] Ranges may be expressed herein as from "about" one particular value and / or to "about" another particular value. When such a range is expressed, another embodiment includes from the one particular value and / or to the other particular value. Similarly, when values are expressed as approximations by using the antecedent "about," it is understood that the particular value forms another embodiment. It is also understood that the endpoints of each range are significant both relative to the other endpoint and independently of the other endpoint.
[0075] Components that can be used to perform the disclosed methods and systems are disclosed. These and other components are disclosed herein, and it should be understood that when combinations, subsets, interactions, groups, etc. of these components are disclosed, although specific references to each of the various individual and common combinations and permutations of these may not be explicitly disclosed, for all methods and systems, each is specifically contemplated and described herein. This applies to all aspects of the application, including but not limited to the steps in the disclosed methods. Therefore, if there are multiple additional steps that can be performed, it should be understood that each arrangement of these additional steps can be performed with any specific embodiment or combination of embodiments of the disclosed methods.
[0076] As will be appreciated by those skilled in the art, the methods and systems may take the form of an entirely hardware embodiment, an entirely software embodiment, or an embodiment combining software and hardware aspects. In addition, the methods and systems may take the form of a computer program product on a computer-readable storage medium having computer-readable program instructions (e.g., computer software) embodied in the storage medium. More particularly, the present methods and systems may take the form of web-implemented computer software. Any suitable computer-readable storage medium may be utilized, including a hard disk, a CD-ROM, an optical storage device, or a magnetic storage device.
[0077] Embodiments of the method and system are described below with reference to block diagrams and flow charts of the method, system, device, and computer program product. It is to be understood that each box in the block diagram and flow chart diagram and the combination of boxes in the block diagram and flow chart diagram can be implemented by computer program instructions, respectively. These computer program instructions can be loaded onto a general-purpose computer, a special-purpose computer, or other programmable data processing device of a production machine, so that the instructions executed on the computer or other programmable data processing device create a module for implementing the functions specified in one or more flow chart boxes.
[0078] These computer program instructions may also be stored in a computer-readable memory, which may direct a computer or other programmable data processing device to function in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture including computer-readable instructions for implementing the functions specified in one or more flowchart blocks. The computer program instructions may also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device, thereby producing a computer-implemented process, so that the instructions executed on the computer or other programmable device provide steps for implementing the functions specified in one or more flowchart blocks.
[0079] Therefore, the blocks of the block diagrams and flowcharts support combinations of modules for performing specified functions, combinations of steps for performing specified functions, and program instruction modules for performing specified functions. It is also understood that each block of the block diagrams and / or flowcharts and combinations of blocks in the block diagrams and / or flowcharts can be implemented by a dedicated hardware-based system or a combination of dedicated hardware and computer instructions that performs the specified functions or steps.
[0080] The present method and system may be understood more readily by reference to the following detailed description of the preferred embodiments and the Examples included therein and by reference to the Drawings and their preceding and following descriptions.
[0081] It should be understood that throughout this specification, the identifiers "first", "second", "third", "fourth", "fifth", "sixth", etc. are used merely to help distinguish the various components and steps of the disclosed subject matter. The identifiers "first", "second", "third", "fourth", "fifth", "sixth", etc. are not intended to imply any particular order, sequence, quantity, preference, or importance of the components or steps modified by these terms.
[0082] Figure 1 is a block diagram of an exemplary system for performing endotoxin analysis of a fluid sample 102. Figure 1 In the embodiment of the present invention, the analyzer 104 receives the fluid sample 102. Non-limiting examples of analyzers that may be used include Sievers 104, as available from SUEZ Water Technologies & Solutions (Boulder, Colorado). TM Total Organic Carbon (TOC) Analyzer and Instrument. The analyzer 104 performs analysis of the fluid sample 102 and provides raw data 106, which can be further analyzed to determine the bacterial endotoxin concentration in the sample 102 (Bacterial Endotoxin Test (BET)). Exemplary systems and methods for performing analysis of the fluid sample 102 are shown and described in U.S. Patent 9,678,079, issued on June 13, 2017, which is incorporated by reference in its entirety.
[0083] The raw data 106 is provided to a data analysis processor 108 which analyzes the raw data 106 using analysis software 110. It should be appreciated that the data analysis processor 108 may be integrated into and part of the analyzer 104 or it may be a separate processor such as a standalone computer or analysis device.
[0084] For the purpose of detecting endotoxin, the analysis software 110 interpolates the raw data 106 from the analyzer 104 to detect changes in optical density over time. Embodiments of the analysis software 110 may be used to analyze raw data from other types of analyzers, such as those that provide measurements based on changes in optical properties (e.g., absorbance, brightness, fluorescence, etc.).
[0085] One embodiment of the analysis software 110 utilizes SQL Server and can be installed standalone (database resides on the lab PC itself) or as a client / server (SQL database resides on a remote server and the client application is installed on the lab PC). The software application 110 is highly customizable and allows each organization to assign user roles and permissions based on their quality management system. The program tracks products, attachments, analysts, eclipse microplate lots, LAL lots, assay performance (%CV, R values, PPC recoveries, etc.) and more for ongoing trends.
[0086] Figures 2A-2K is a diagram of an exemplary graphical user interface (GUI) of one embodiment of the analysis software described herein. Figures 2A-2K As shown, the analysis software 110 includes a unique "Pharmacopeia" section within the menu navigation - this section contains test settings and test results for those tests that are directly related to regulatory requirements and / or validation and routine maintenance (such as analyst qualification, 1:1 ratio validation, and lysate identification). The "Diagnostics" section also allows the customer to implement firmware upgrades or run temperature validation or optical validation tests. Upon login, the navigation menu in the analysis software 110 can be minimized or enlarged, and any subcategory of the menu can be quickly accessed. Finally, the analysis software 110 distinguishes itself from traditional BET software by providing a colorful and descriptive GUI or report 112, as shown in Figure 3A and Figure 3B As shown in and described below.
[0087] Visualization of endotoxin response
[0088] During the endotoxin reaction in the test (e.g., with a test reagent), useful information is the progress of the reaction when reaching the starting threshold (e.g., how fast the reaction reaches the starting threshold; how long before the reaction reaches the starting threshold; and how the reaction progresses relative to the related reactions of the same test group, etc.). An embodiment of real-time visualization generates a bar graph for each reaction chamber (test well) to display the progress of the measured reaction to the starting threshold. For example, the measured reactions of all holes are presented simultaneously to provide a simultaneous view of all states of the endotoxin reaction of the microplate test. Real-time visualization facilitates the visualization of various progresses (e.g., the progress of a single hole, the progress of a single hole relative to a group, the progress of a standard hole, etc.) of the starting threshold of the endotoxin reaction of a given plate. For example, real-time visualization can facilitate the identification of whether the reaction of a hole or a group of holes with a faster or slower reaction meets expectations.
[0089] Embodiments of the real-time visualization can be used with analysis software to analyze and / or view raw data from various analyzers, including those that provide measurements based on changes in optical properties (e.g., absorbance, brightness, fluorescence, etc.) for visualization of endotoxin reaction progress.
[0090] In fact, if Figure 3A and Figure 3B As shown, the GUI or report 112 includes a graphical visualization 300 generated, for example, by the data analysis processor 108 executing the analysis software 110, which has the following features: The kinetics of the reactions were visualized in the form of side-by-side vertically oriented bar graphs of 104 reactions occurring when the microplate was manufactured by SUEZ Technologies & Solutions, Boulder, Colorado (although microplates from different manufacturers with optical apertures are contemplated to be within the scope of the embodiments described herein). Figure 3A and Figure 3B As shown, each vertical bar 302 of the side-by-side bar graph represents the progress of the endotoxin reaction for each associated optical well of the microplate (e.g., which can be associated with an optical density (OD) reading, a change in an optical property, etc.). A standard microplate typically has 96 wells or more. The instant GUI 112 has a graphical visualization of 104 wells, but the disclosed visualization embodiments can be adapted to 96 wells or more.
[0091] Still reference Figure 3A and Figure 3B , the optical well of the sample is identified by the sample segment number 303 shown horizontally across the bottom of the GUI or report 112. When the reaction between one or more test reagents (such as horseshoe crab amebocyte lysate (LAL) or its synthetic substitute (such as recombinant factor C (rFC), horseshoe crab coagulation factor C, horseshoe crab thrombin, etc.)) and bacterial endotoxin occurs in each well, the vertical bar 302 increases over time. In fact, the more endotoxins there are in the optical well (regardless of whether they are related to the sample, endotoxin standard or positive product control), the faster the reaction with the test reagent occurs, and the faster the relevant bar increases subsequently. The horizontal line 304 (labeled as "starting threshold" 304) on the graphical visualization represents the threshold OD or starting OD. The time when any given reaction crosses the threshold is called "start time" or "reaction time". In some embodiments, the vertical bars associated with the endotoxin standard (306) and the negative control (308) are marked with one color (e.g., red) in each test before reaching the starting threshold, while the vertical bar representing the sample 302 may be marked with a different color (e.g., blue) before reaching the starting threshold. Once the vertical bar 302 reaches the starting threshold (e.g., line 304), in some embodiments and as Figure 3A and Figure 3BAs shown, the GUI is configured to adjust the color of the bar 302 of the graphical visualization 300 (eg, from red or blue to green) to indicate that a given well has reached the starting threshold state.
[0092] The GUI or report 112 provides the user with a comprehensive and global view of the progress of the kinetic reactions occurring in all wells of an exemplary microplate (eg, a 96-well microplate, a 104-well microplate, etc.).
[0093] Figure 4A , Figure 4B and Figure 4C Both show how the reaction rate, the progress of the reaction, and the relative progress of the reaction can be viewed from real-time visualization according to illustrative embodiments. Figure 4A , Figure 4B and Figure 4C In FIG. 1 , a visualization of GUI 112 is provided at three different time instants of the same test. Figure 4A In the visualization, a snapshot of the test at runtime 1459 seconds is shown; Figure 4B shows a snapshot of the test at runtime 1579 seconds; and Figure 4C A snapshot of the test at run time 2124 seconds is shown. Figure 4A and Figure 4B As can be observed in FIG. 1 , the standard wells are represented by red and (when the measurement approaches the starting threshold) turn to a darker red and then turn to green when the threshold is crossed. Similarly, the test wells are represented by blue and (when the measurement approaches the starting threshold) turn to a darker blue and then turn to green when the threshold is crossed. Also, as in FIG. Figure 4A and Figure 4B It can be observed that when the measured level approaches the starting threshold, the vertical bar of the specific well turns from red and blue to dark red and dark blue. Figure 4C The vertical bars showing the wells turn green when the starting threshold line is crossed.
[0094] As indicated above, the higher the endotoxin concentration in the standard curve, the faster the reaction should be, and using dynamic view, the user can quickly identify the possible error in the standard curve (for example, 5.0-EU / mL standard reacts faster than 50-EU / mL standard) or negative control 308, and if allowed, the test may be stopped due to invalid test to accelerate the retest process. In addition, positive product control (PPC) 310 is a product sample (often referred to as " spike (spiked) " or " product spike (product spikes) ") in which a known amount of endotoxin is added to a product sample, and this is completed when endotoxin concentration is in the middle of the standard curve range (for example 0.5EU / mL). Optionally, positive product control 310 can be calculated as the difference between the endotoxin concentration in PPC and the endotoxin concentration in the sample, and this difference is divided by the actual endotoxin concentration of 0.5EU / mL standard. In another embodiment, instead of dividing by the actual calculated value in each test or each test, the positive product control 310 is calculated as the difference between the endotoxin concentration in the PPC and the endotoxin concentration in the sample, and the difference is divided by a constant nominal 0.5 concentration. Utilizing the function of the GUI shown, the end user can observe the reaction rate, the progress of the reaction and the relative progress of the reaction of all sample PPCs (e.g., 21 sample PPCs), while observing the reaction rate, the progress of the reaction and the relative progress of the reaction of the endotoxin standard under the same concentration (e.g., 0.5EU / mL). In the case of this comprehensive and global perspective, the analyst or technician performing the test can quickly identify whether the sample PPC is correctly performing to reclaim the required 50-200% of the added endotoxin. If the analyst or technician suspects that the sample will not pass, they can act quickly to prepare the following steps and actions according to their quality management system (QMS).
[0095] Currently, software applications for LAL tests and the like display a kinetic reaction curve of endotoxin in a sample over a period of reaction time. In some embodiments, these software display the results in a matrix format, which does not provide the same rapid and comprehensive information about the endotoxin reaction rate, the progress of the endotoxin reaction, and the relative progress of the endotoxin reaction. Figure 5A is an example visualization of the progression of a kinetic test in a LAL test in a 96-well microplate. Figure 5B is a visual example of this progression once the testing is complete.
[0096] Endotoxin measurements in injectable pharmaceutical products or water are typically performed in 96-well microplates. Existing systems are usually in the form of graphs (e.g. Figure 5A and Figure 5B) display the measured level (e.g., absorbance level), which makes it difficult to evaluate or compare the reaction speeds of different wells. In addition, these graphs do not facilitate the identification of unexpected reactions (e.g., whether a well reacts too slowly or too quickly, or whether a well reacts consistently with other wells in the same group (i.e., aligned with other wells). In contrast, side-by-side vertically oriented bar graphs can facilitate such identification more easily and intuitively.
[0097] In another aspect, the microplates may be arranged, for example, in specific groupings to provide a more intuitive view for evaluating the progress of the LAL test. Fig. 6A Shown is a time series kinetic response graph of a 104-well microplate arranged to provide a more intuitive review of the assessment of the progress of the LAL assay. Figure 6B and Figure 6C The same situation is shown at different viewing scale levels. As shown, the vertical axis is scaled to accommodate the sample being measured. In addition, the x-axis is scaled for HD displays (higher resolution).
[0098] In another aspect, when a well is selected (eg, via a cursor or keyboard), the live visualization may provide detailed information for a given well. Figure 4A Detailed information about the sample (402) is shown, such as the test name (404), test type (406), optical density threshold (408), product sample identifier (410), and dilution ratio (412).
[0099] In another aspect, instant visualization including side-by-side vertically oriented bar graphs can be used to view other parameters associated with measurement results or analysis. In certain embodiments, instant visualization is used to view the measured value (e.g., optical properties (e.g., absorbance, fluorescence, cold light) of each hole in the microplate in a side-by-side vertical orientation mode together with the change of other properties disclosed herein). In certain embodiments, instant visualization is used to view the determined start time value of each hole in the microplate in a side-by-side vertical orientation mode. In certain embodiments, instant visualization is used to view the measured endotoxin concentration value of each hole in the microplate in a side-by-side vertical orientation mode. In certain embodiments, instant visualization is used to view the measured PPC recovery value of each hole in the microplate in a side-by-side vertical orientation mode. In certain embodiments, instant visualization is used to view the assessed matrix effect value of each hole in the microplate in a side-by-side vertical orientation mode.
[0100] Figure 7 , Figure 8 , Fig. 9 , Fig.10 , Fig.11 , Fig.12 , Fig.13Each shows example views of example parameters of wells or groups of wells in a microplate that may be displayed in a side-by-side vertical orientation according to one embodiment.
[0101] Figure 7 Shown are example views of measured absorbance levels (eg, in AU) of wells in a microplate displayed in a side-by-side vertical orientation. Figure 8 An example view of the estimated start times (eg, in seconds) of wells in a microplate displayed in a side-by-side vertical orientation is shown. Fig. 9 An example view of two-point coefficient of variation values (eg, as a percentage) for wells in a microplate displayed in a side-by-side vertical orientation is shown. Fig.10 Shown are example views of measured endotoxin concentration values (eg, in EU / ml) for wells in a microplate displayed in a side-by-side vertical orientation. Fig.11 Shown are example views of measured endotoxin concentration values (eg, in EU / ml) for a given sample in a microplate (eg, as an average for a given group of wells) displayed in a side-by-side vertical orientation. Fig.12 Shown are example views of measured PPC recovery values (eg, in EU / ml) for wells in a microplate displayed in a side-by-side vertical orientation. Fig.13 An example view of calculated matrix effect values (eg, unitless) for wells in a microplate displayed in a side-by-side vertical orientation is shown.
[0102] Computing Environment
[0103] The system is described above as being comprised of units. Those skilled in the art will recognize that this is a functional description and that the corresponding functions may be performed by software, hardware, or a combination of software and hardware. The unit may be software, hardware, or a combination of software and hardware. The unit may include software for analyzing a fluid sample for endotoxins. In one exemplary aspect, the unit may include an analyzer and / or a data analysis computer including one or more computing devices, each computing device including a processor, a processor, or a processor. Fig.14 1 and described below. As used herein, a processor refers to a physical hardware device that executes coded instructions for acting on input and producing output.
[0104] Fig.14An exemplary computer that can be used to execute software for analyzing fluid samples for endotoxins is shown. As used herein, "computer" may include multiple computers. The computer may include one or more hardware components, such as a processor 1421, a random access memory (RAM) module 1422, a read-only memory (ROM) module 1423, a storage device 1424, a database 1425, one or more input / output (I / O) devices 1426 and an interface 1427. Alternatively and / or additionally, the computer may include one or more software components, such as a computer-readable medium including computer executable instructions for executing the method associated with the exemplary embodiment. It is contemplated that one or more of the hardware components listed above may be implemented using software. For example, a storage device 1424 may include a software partition associated with one or more other hardware components. It should be understood that the components listed above are merely exemplary and are not defined as restrictive.
[0105] Processor 1421 may include one or more processors, each configured to execute instructions and process data to perform one or more functions associated with a computer for executing software to perform analysis of a fluid sample for endotoxin. Processor 1421 may be communicatively coupled to RAM 1422, ROM 1423, storage device 1424, database 1425, I / O device 1426, and interface 1427. Processor 1421 may be configured to execute a sequence of computer program instructions to perform various processes. Computer program instructions may be loaded into RAM 1422 for execution by processor 1421.
[0106] RAM 1422 and ROM 1423 may each include one or more devices for storing information associated with the operation of processor 1421. For example, ROM 1423 may include a memory device configured to access and store information associated with the computer, including information for identifying, initializing, and monitoring the operation of one or more components and subsystems. RAM 1422 may include a memory device for storing data associated with one or more operations of processor 1421. For example, ROM 1423 may load instructions into RAM 1422 for execution by processor 1421.
[0107] Storage device 1424 may include any type of mass storage device configured to store information that processor 1421 may need to perform processes consistent with the disclosed embodiments. For example, storage device 1424 may include one or more magnetic and / or optical disk devices, such as a hard drive, CD-ROM, DVD-ROM, or any other type of mass media device.
[0108] The database 1425 may include one or more software and / or hardware components that cooperate to store, organize, sort, filter, and / or arrange data used by the computer and / or processor 1421. For example, the database 1425 may store data related to the analysis software. The database may also contain data and instructions associated with computer executable instructions for performing an analysis of a fluid sample for endotoxins and creating a GUI and / or report for the results of the analysis. It is contemplated that the database 1425 may store additional information and / or information different from the information listed above.
[0109] I / O device 1426 may include one or more components configured to be associated with a computer and transmit information to the user. For example, I / O device may include a console with an integrated keyboard and mouse to allow a user to maintain a fluid sample and endotoxin information and databases such as these. I / O device 1426 may also include a display including a graphical user interface (GUI) for outputting information on a monitor. I / O device 1426 may also include peripherals, such as a printer, a user-accessible disk drive (such as a USB port, a floppy disk, a CD-ROM or a DVD-ROM drive, etc.) to allow a user to input data stored on a portable media device, a microphone, a speaker system or any other suitable type of interface device.
[0110] The interface 1427 may include one or more components configured to transmit and receive data via a communication network (e.g., the Internet, a local area network, a workstation peer-to-peer network, a direct link network, a wireless network, or any other suitable communication platform). For example, the interface 1427 may include one or more modulators, demodulators, multiplexers, demultiplexers, network communication devices, wireless devices, antennas, modems, and any other type of device configured to implement data communication via a communication network.
[0111] The accompanying drawings show the architecture, function and operation of the possible implementation of the system, method and computer program product according to various implementations of the present invention. In this regard, each square block of the flow chart or block diagram may represent a module, segment or part of a code, which includes one or more executable instructions for realizing the specified logical function. It should also be noted that in some selectable implementations, the functions mentioned in the square blocks may not occur in the order mentioned in the figure. For example, the two square blocks shown continuously can in fact be performed substantially simultaneously, or the square blocks can sometimes be performed in reverse order, depending on the functions involved. It should also be noted that each square block in the block diagram and / or flow chart description, and the combination of the square blocks in the block diagram and / or flow chart description, can be implemented by a combination of a system based on special-purpose hardware or special-purpose hardware and computer instructions that performs a specified function or action.
[0112] The corresponding structures, materials, operations and equivalent replacements of all functionally defined devices or steps in the following claims are intended to include any structure, material or action for performing the function in combination with other elements specifically pointed out in the claims. The description of the present invention is presented for the purpose of illustration and description, but is not intended to be exhaustive or limited to the present invention in the disclosed form. Many modifications and changes will be obvious to those of ordinary skill in the art without departing from the scope and spirit of the present invention. Implementations are selected and described in order to best explain the principles and practical applications of the present invention and enable those of ordinary skill in the art to understand the present invention for various implementations with various modifications such as those suitable for the specific purposes envisioned.
[0113] Any combination of one or more computer-readable media can be used to implement the systems and methods described above. Computer-readable media can be computer-readable signal media or computer-readable storage media. Computer-readable storage media can be, for example, but not limited to, electronic, magnetic, optical, electromagnetic, infrared or semiconductor systems, devices or equipment, or any suitable combination of the foregoing. More specific examples (non-exhaustive list) of computer-readable media can include the following items: electrical connections with one or more wires, portable computer disks, hard disks, random access memories (RAM), read-only memories (ROM), erasable programmable read-only memories (EPROM or flash memory), optical fibers, portable compact disk read-only memories (CD-ROM), optical storage devices, magnetic storage devices, or any suitable combination of the foregoing. In the context of this document, computer-readable storage media can be any tangible medium that can contain or store programs used by an instruction execution system, device or device or in conjunction with an instruction execution system, device or device.
[0114] A computer readable signal medium may include a propagated data signal in which a computer readable program code is embodied, for example in baseband or as part of a carrier wave. Such a propagated signal may take any of a variety of forms, including but not limited to electromagnetic, optical, or any suitable combination thereof. A computer readable signal medium may be any computer readable medium that is not a computer readable storage medium and that may convey, propagate, or transmit a program used by or in conjunction with an instruction execution system, device, or apparatus.
[0115] Program code embodied on a computer readable medium may be transmitted using any appropriate medium, including but not limited to wireless, wireline, optical fiber cable, RF, etc., or any suitable combination of the foregoing.
[0116] Computer program code for performing operations of aspects of the present invention may be written in any combination of one or more programming languages, including object-oriented programming languages (e.g., Java, Smalltalk, C++, or the like) and conventional procedural programming languages (e.g., the "C" programming language or similar programming languages). The program code may be executed entirely on the user's computer, as a stand-alone software package, partially on the user's computer and partially on a remote computer, or entirely on a remote computer or server. In the latter scenario, the remote computer may be connected to the user's computer through any type of network, including a local area network (LAN) or a wide area network (WAN), or may be connected to an external computer (e.g., via the Internet using an Internet service provider).
[0117] Aspects of the present invention are described herein with reference to flowchart illustrations and / or block diagrams of methods, devices (systems) and computer program products according to implementations of the present invention. It is to be understood that each box of the flowchart illustration and / or block diagram, as well as the combination of boxes in the flowchart illustration and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, or other programmable data processing device for producing a machine, so that instructions executed by a processor of a computer or other programmable data processing device create functions / actions specified in a flowchart and / or in one or more boxes of a block diagram.
[0118] These computer program instructions may also be stored in a computer-readable medium, which may direct a computer, other programmable data processing apparatus, or other device to function in a specific manner so that the instructions stored in the computer-readable medium produce an article of manufacture including instructions for implementing the functions / actions specified in one or more blocks of the flowchart and / or block diagram.
[0119] The computer program instructions may also be downloaded to a computer, other programmable data processing apparatus, or other device so that a series of operational steps to be performed on the computer, other programmable apparatus, or other device produces a computer-implemented process, so that the instructions executed on the computer or other programmable apparatus provide a process for implementing the functions / actions specified in one or more blocks of the flowchart and / or block diagram.
[0120] Although the subject matter has been described in language specific to structural features and / or methodological acts, it should be understood that the subject matter defined in the appended claims is not necessarily limited to the specific features or acts described above. Rather, the specific features and acts described above are disclosed as example forms of implementing the claims.
[0121] Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the spirit and scope of the present invention, including but not limited to changes and modifications associated with the chemical structures, substituents, derivatives, intermediates, synthetics, compositions, formulations or methods of use of the present invention.
[0122] While the method and system have been described in conjunction with preferred embodiments and specific examples, it is not intended that the scope be limited to the specific embodiments set forth, as the embodiments herein are intended to be illustrative in all respects rather than restrictive.
[0123] Unless expressly stated otherwise, it is not intended that any method set forth herein be interpreted as requiring that its steps be performed in a specific order. Therefore, where a method claim does not actually recite the order in which its steps are to be followed or otherwise does not specifically state in the claim or description that the steps should be limited to a specific order, it is not intended that the order be inferred in any respect. This applies to any possible non-express basis for interpretation, including logical matters regarding the arrangement of steps or operational flow; explicit meaning derived from grammatical organization or punctuation; the number or type of embodiments described in the specification.
[0124] Throughout this application, various publications may be referenced. The disclosures of these publications are hereby incorporated by reference in their entireties into this application in order to more fully describe the state of the art to which the methods and systems pertain, and to illustrate the improvements over the state of the art in the claimed inventions.
[0125] For the purpose of explanation, the foregoing description uses specific terms to provide a thorough understanding of the described embodiments. However, it will be apparent to those skilled in the art that specific details are not required in order to practice the described embodiments. Therefore, the foregoing descriptions of the specific embodiments described herein are presented for the purpose of illustration and description. They are not intended to be exhaustive or to limit the disclosure to the precise form disclosed. It will be apparent to those of ordinary skill in the art that many modifications and variations are possible in view of the above teachings.
[0126] It will be apparent to those skilled in the art that various modifications and variations may be made without departing from the scope or spirit. Other embodiments will be apparent to those skilled in the art from consideration of the specification and practice disclosed herein. It is intended that the specification and examples be considered exemplary only, with the true scope and spirit being indicated by the appended claims.
[0127] According to an embodiment of the present invention, there is provided:
[0128] Item 1). A computer-implemented method for generating a visualization of endotoxin concentration in a fluid sample, the method comprising:
[0129] generating, by a processor, a graphical visualization for a graphical user interface or report to be displayed on a fixed or mobile computing device based on a data set identifying optical density (OD) readings of a microplate comprising a plurality of optical wells, each optical well containing a fluid sample, the graphical visualization comprising a vertically oriented bar graph having a plurality of vertical bars, at least one vertically oriented bar graph for each optical well of the microplate,
[0130] wherein the processor causes the vertically oriented bar graph corresponding to the optical well of the microplate to increase vertically over time when a reaction between horseshoe crab amebocyte lysate (LAL) and bacterial endotoxin occurs in the optical well of the microplate,
[0131] Therein, the greater the amount of endotoxin present in the optical well, the faster the reaction with the LAL reagent occurs and subsequently the processor causes the associated vertically oriented bar graph to increase on the graphical visualization.
[0132] Item 2). The computer-implemented method according to Item 1) further includes generating, by the processor, a horizontal line representing a threshold OD or a starting OD on the graphical visualization, wherein the time when the vertically oriented bar graph corresponding to the optical hole reaches or crosses the horizontal line is referred to as the "starting time" or "reaction time" of the fluid sample in the optical hole corresponding to the vertically oriented bar graph reaching or crossing the horizontal line.
[0133] Item 3). A computer-implemented method according to Item 2), wherein once the vertically oriented bar graph reaches the horizontal line, the processor causes the color of the vertically oriented bar graph to change from a first color to a second color.
[0134] Item 4). A computer-implemented method according to item 3), wherein the first color is blue and the second color is green.
[0135] Item 5). The computer-implemented method according to any one of items 1)-4), further comprising generating, by the processor, a vertically oriented bar graph representing endotoxin standards and negative controls that is also displayed on the graphical visualization.
[0136] Item 6). A computer-implemented method according to any one of Items 1)-5), wherein the vertically oriented bar graph representing the endotoxin standard is marked by the processor with a first color, the vertically oriented bar graph representing the negative control is marked by the processor with a second color, and the vertically oriented bar graph corresponding to the optical hole of the microplate is marked by the processor with a third color.
[0137] Item 7). A computer-implemented method according to any one of Items 1)-6), wherein the vertically oriented bar graph representing the endotoxin standard is marked by the processor with a darker green color, the vertically oriented bar graph representing the negative control is marked by the processor with red color, and the vertically oriented bar graph corresponding to the optical hole of the microplate is marked by the processor with blue or lighter green color.
[0138] Item 8). A computer-implemented method according to any one of Items 1)-7), wherein the vertically oriented bar graph representing the endotoxin standard is marked by the processor with a darker green color, the vertically oriented bar graph representing the negative control is marked by the processor with red color, and the vertically oriented bar graph corresponding to the optical hole of the microplate is marked by the processor with blue color, until the vertically oriented bar graph corresponding to the optical hole of the microplate reaches the horizontal line representing the threshold OD or the starting OD generated by the processor on the graphic visualization, and the vertically oriented bar graph corresponding to the optical hole of the microplate is turned green by the processor when the vertically oriented bar graph corresponding to the optical hole of the microplate reaches the horizontal line representing the threshold OD or the starting OD generated by the processor on the graphic visualization.
[0139] Item 9). The computer-implemented method according to any one of items 1)-8), further comprising generating, by the processor, a vertically oriented bar graph representing a positive product control on the graphical visualization.
[0140] Item 10). A computer-implemented method according to any one of Items 1)-9), wherein, once the vertically oriented bar graph corresponding to the optical hole of the microplate reaches a horizontal line generated by the processor on the graphical visualization, the vertically oriented bar graph representing a positive product control is marked by the processor using the same color as that used by the processor to mark the vertically oriented bar graph corresponding to the optical hole of the microplate, wherein the horizontal line represents a threshold OD or a starting OD.
[0141] Item 11). A computer-implemented method according to any one of items 1)-10), wherein the vertically oriented bar graph representing a positive product control is marked by the processor using green.
[0142] Item 12). A computer-implemented method according to any one of Items 10)-11), wherein the positive product control is calculated by the processor according to the following operations: the endotoxin concentration in the PPC minus the endotoxin concentration in the sample and then divided by the actual endotoxin concentration of the 0.5EU / mL standard.
[0143] Item 13). A system for executing the computer-implemented method according to any one of items 1)-12).
[0144] Item 14). A non-transitory computer-readable medium comprising computer-executable instructions, wherein, when executed, the computer-executable instructions cause a processor to perform a computer-implemented method according to any one of items 1)-12).
[0145] Item 15). A graphical user interface generated by a computer-implemented method according to any one of items 1)-12).
[0146] Item 16). A system for testing endotoxins in an injectable drug product or water, the system comprising:
[0147] Processor; and
[0148] a memory having instructions stored on the memory, wherein execution of the instructions by the processor causes the processor to:
[0149] continuously obtaining one or more data sets associated with measurement results of the multiwell microplate during acquisition of the measurement results of the multiwell microplate, wherein each measurement result is associated with i) a measured level of endotoxin in an acquired sample of an injectable drug product or water over time and ii) an endotoxin reaction of one or more test agents, and wherein the data sets include a current measured level of endotoxin reaction for each well of the multiwell microplate, wherein the multiwell microplate includes at least 96 wells; and
[0150] in a pane of a graphical user interface, exclusively displaying a side-by-side graphic including a plurality of visual elements based on the acquired data set, wherein each visual element of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate,
[0151] wherein each of the plurality of visual elements comprises a vertically oriented bar configured to display a data value spanning a range between a minimum value and a maximum value, wherein each of the minimum value and the maximum value is aligned with a respective first horizontal line and a second horizontal line,
[0152] wherein the graphical user interface further comprises a visual element comprising a third horizontal line at a value indicating a starting threshold of an endotoxin reaction in each well or well group of the at least 96 wells of the multi-well microplate, and
[0153] wherein the side-by-side pattern of the at least 96 wells of the multiwell microplate provides a simultaneous comparison of the progression of an endotoxin reaction in the at least 96 wells or groups of wells of the multiwell microplate to test for endotoxin in an acquired sample of an injectable pharmaceutical product or water.
[0154] Item 17). A system according to Item 16), wherein the side-by-side graphic of the at least 96 wells of the multi-well microplate provides an indication of incorrectly configured wells, and wherein the indication is used to retest the sample of injectable drug product or water in the incorrectly configured wells in a subsequent test or to evaluate the retesting of the sample.
[0155] Item 18). A system according to Item 16) or 17), wherein the one or more data sets associated with the measurement results of the multiwell microplate having the at least 96 wells are continuously acquired and displayed at predetermined intervals of at least once per second, wherein the intervals are fixed to provide an observation of the rate of endotoxin reaction in the at least 96 wells or a portion of the at least 96 wells.
[0156] Item 19). A system according to any one of items 16)-18), wherein the instructions, when executed by the processor, cause the processor to:
[0157] receiving input from an input device, wherein the input is associated with a cursor of the graphical user interface;
[0158] determining, in the pane of the graphical user interface, that the cursor is placed over one of the plurality of visual elements for at least one selection of the group consisting of selections of visual elements or that the cursor is placed over one of the plurality of visual elements for a predetermined period of time; and
[0159] Displayed in the pane or the second pane of the graphical user interface is i) a graph of measured levels of endotoxin response over time for the one or more wells where the cursor is placed or ii) a measurement parameter associated with the one or more wells where the cursor is placed.
[0160] Item 20). A system according to Item 19), wherein a graph of the changes in the measured level of endotoxin response over time is presented, and wherein the graph of the changes in the measured level of endotoxin response over time includes one or more kinetic curves for a selected well over a reaction time.
[0161] Item 21). The system according to any one of items 16)-20), further comprising:
[0162] The graphical user interface has a horizontal pixel element greater than twice the number of wells of the multi-well microplate.
[0163] Item 22). A system according to Items 16)-21), wherein the graphical user interface has a set of vertical pixel elements, and wherein each of the plurality of visual elements spans at least 80% of the set of vertical pixel elements.
[0164] Item 23). A system according to any one of Items 16)-22), wherein a portion of the at least 96 wells of the multi-well microplate includes a group of one or more standard wells, the group of one or more standard wells including a first standard well and a second standard well, wherein the visual elements associated with the first standard well and the second standard well have a color different from that of the remaining portion of the at least 96 wells of the multi-well microplate.
[0165] Item 24). The system according to any one of items 16)-23), further comprising:
[0166] A sensor system configured to interrogate the at least 96 wells of the multiwell microplate for a measurement of a measured level of an endotoxin reaction in the multiwell microplate, wherein the sensor system comprises one or more sensors selected from the group consisting of an absorbance sensor, a fluorescence sensor, and a luminescence sensor.
[0167] Item 25). A system according to Item 24), wherein the sensor system is configured as a 96-well microplate.
[0168] Item 26). A system according to Item 24), wherein the sensor system is configured as a 104-well microplate.
[0169] Item 27). A system according to any one of Items 16)-26), wherein the measured level of endotoxin reaction includes a value associated with a measured change in the transparency of a sample obtained of the injectable drug product or water associated with a reaction with the one or more test reagents.
[0170] Item 28). A system according to any one of Items 16)-27), wherein the measured level includes a value associated with a measured change in an optical property of an acquired sample of the injectable drug product or water associated with a reaction with the one or more test reagents, the optical property being selected from the group consisting of absorbance, brightness, fluorescence, and a combination of the absorbance, brightness, and fluorescence.
[0171] Item 29). A system according to any one of Items 16)-28), wherein the plurality of visual elements include a first group of visual elements associated with a standard hole, a second group of visual elements associated with a standard hole, a third group of visual elements associated with a standard hole, a fourth group of visual elements associated with a standard hole, a fifth group of visual elements associated with a standard hole, and a sixth group of visual elements associated with a standard hole,
[0172] wherein the first set of visual elements has a 50-EU / ml standard,
[0173] wherein the second set of visual elements has a 5-EU / ml standard,
[0174] Wherein, the third group of visual elements has a 0.5-EU / ml standard,
[0175] Wherein, the fourth group of visual elements has a 0.05-EU / ml standard,
[0176] wherein the fifth set of visual elements has a 0.005-EU / ml standard, and
[0177] Wherein, the sixth group of visual elements has a negative control standard.
[0178] Item 30). A system according to any one of items 16)-29), wherein the value indicating the starting threshold is user selectable.
[0179] Item 31). A system according to any one of items 16)-30), wherein the instructions, when executed by the processor, cause the processor to:
[0180] receiving input from an input device, wherein the input is associated with selection of a measurement parameter for the multiwell microplate, the measurement parameter being selected from the group consisting of: a measured start time, a measured endotoxin concentration, a measured positive product control (PPC) recovery, and a determined matrix effect;
[0181] obtaining one or more second data sets associated with the selected parameters; and
[0182] In the pane or the second pane of the graphical user interface, a second plurality of visual elements associated with the selected parameter are displayed, wherein the second plurality of visual elements have a quantity corresponding to the at least 96 wells or a portion of the at least 96 wells.
[0183] Item 32). A method for monitoring endotoxin testing in an injectable drug product or water, the method comprising:
[0184] obtaining, by a processor, one or more data sets associated with measurements of a multi-well microplate, wherein each measurement is associated with a measured level of endotoxin in a captured sample of an injectable drug product or water over time, wherein the data sets include a current measured level for each well of the multi-well microplate, wherein the multi-well microplate includes at least 96 wells; and
[0185] displaying, by the processor, in a pane of a graphical user interface, a side-by-side graphic comprising a plurality of visual elements exclusively based on the acquired data set, wherein each of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate,
[0186] wherein each of the plurality of visual elements comprises a vertically oriented bar configured to span data values ranging between a minimum value and a maximum value, wherein each of the minimum value and the maximum value coincides with a first horizontal line and a second horizontal line,
[0187] wherein the graphical user interface further comprises a visual element comprising a third horizontal line at a measured value indicating a starting threshold for each of the at least 96 wells of the multi-well microplate, and
[0188] wherein the side-by-side pattern of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the rates of reactions in the at least 96 wells or groups of wells of the multi-well microplate to monitor testing for endotoxins in acquired samples of injectable pharmaceutical products or water.
[0189] Item 33). The method according to Item 32) further includes:
[0190] For acquiring the measured level of endotoxin reaction in the multiwell microplate, the at least 96 wells of the multiwell microplate are interrogated by a sensor system, wherein the sensor system includes one or more sensors selected from the group consisting of absorbance sensors, fluorescence sensors and luminescence sensors.
[0191] Item 34). A non-transitory computer-readable medium having instructions stored thereon, wherein execution of the instructions by a processor causes the processor to:
[0192] obtaining one or more data sets associated with measurements of a multi-well microplate, wherein each measurement is associated with a measured level of endotoxin in a sample obtained of an injectable drug product or water over time, wherein the data sets include a current measured level for each well of the multi-well microplate, wherein the multi-well microplate includes at least 96 wells; and
[0193] in a pane of a graphical user interface, exclusively displaying a side-by-side graphic including a plurality of visual elements based on the acquired data set, wherein each visual element of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate,
[0194] wherein each of the plurality of visual elements comprises a vertically oriented bar configured to span data values ranging between a minimum value and a maximum value, wherein each of the minimum value and the maximum value coincides with a first horizontal line and a second horizontal line,
[0195] wherein the graphical user interface further comprises a visual element comprising a third horizontal line at a measured value indicating a starting threshold for each of the at least 96 wells of the multi-well microplate, and
[0196] wherein the side-by-side pattern of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the rates of reactions in the at least 96 wells or groups of wells of the multi-well microplate to monitor testing for endotoxins in acquired samples of injectable pharmaceutical products or water.
[0197] Item 35). A non-transitory computer-readable medium according to Item 34), wherein the instructions, when executed by the processor, further cause the processor to:
[0198] controlling a sensor system configured to interrogate and acquire measurement results of the at least 96 wells of the multiwell microplate with respect to the measured level of endotoxin reaction in the multiwell microplate, wherein the sensor system comprises one or more sensors selected from the group consisting of absorbance sensors, fluorescence sensors, and luminescence sensors.
Claims
1. A computer-implemented method for generating a visualization of endotoxin concentration in a fluid sample, the method include: generating, by a processor, a graphical visualization for a graphical user interface or report to be displayed on a fixed or mobile computing device based on a data set identifying optical density (OD) readings of a microplate comprising a plurality of optical wells, each optical well containing a fluid sample, the graphical visualization comprising a vertically oriented bar graph having a plurality of vertical bars, at least one vertically oriented bar graph for each optical well of the microplate, wherein the processor causes the vertically oriented bar graph corresponding to the optical well of the microplate to increase vertically over time when a reaction between horseshoe crab amebocyte lysate (LAL) and bacterial endotoxin occurs in the optical well of the microplate, wherein the greater the amount of endotoxin present in the optical well, the faster the reaction with the LAL reagent occurs and subsequently the processor causes the associated vertically oriented bar graph to increase on the graphical visualization; wherein the method further comprises generating, by the processor, a vertically oriented bar graph representing endotoxin standards and negative controls that is also displayed on the graphical visualization, and Wherein, the method further includes generating, by the processor, a vertically oriented bar graph representing a positive product control on the graphical visualization.
2. The computer-implemented method of claim 1 , further comprising generating, by the processor, a horizontal line on the graphical visualization representing a threshold OD or a starting OD, in, The time when the vertically oriented bar graph corresponding to the optical well reaches or crosses the horizontal line is referred to as the "start time" or "reaction time" of the fluid sample in the optical well corresponding to the vertically oriented bar graph reaching or crossing the horizontal line.
3. The computer-implemented method of claim 2, in, The processor causes the color of the vertically-oriented bar graph to change from a first color to a second color once the vertically-oriented bar graph reaches the horizontal line.
4. The computer-implemented method of claim 3, in, The first color is blue, and the second color is green.
5. The computer-implemented method of claim 1, in, The vertically oriented bar graph representing the endotoxin standard is marked by the processor with a first color, the vertically oriented bar graph representing the negative control is marked by the processor with a second color, and the vertically oriented bar graph corresponding to the optical well of the microplate is marked by the processor with a third color.
6. The computer-implemented method of claim 5, in, The vertically oriented bars representing the endotoxin standards are marked by the processor in a darker green color, the vertically oriented bars representing the negative controls are marked by the processor in red, and the vertically oriented bars corresponding to the optical wells of the microplate are marked by the processor in blue or lighter green.
7. The computer-implemented method of claim 5, in, The vertically oriented bar graph representing the endotoxin standard is marked by the processor with a darker green color, the vertically oriented bar graph representing the negative control is marked by the processor with red color, and the vertically oriented bar graph corresponding to the optical wells of the microplate is marked by the processor with blue color until the vertically oriented bar graph corresponding to the optical wells of the microplate reaches a horizontal line representing a threshold OD or a starting OD generated by the processor on the graphical visualization, at which time the vertically oriented bar graph corresponding to the optical wells of the microplate turns green by the processor.
8. The computer-implemented method according to any one of claims 1 to 7, in, Once the vertically oriented bar graph corresponding to the optical well of the microplate reaches a horizontal line generated by the processor on the graphical visualization, the vertically oriented bar graph representing a positive product control is marked by the processor using the same color that is used by the processor to mark the vertically oriented bar graph corresponding to the optical well of the microplate, wherein the horizontal line represents a threshold OD or a starting OD.
9. The computer-implemented method according to any one of claims 1 to 7, in, The vertically oriented bar graph representing a positive product control is marked by the processor using a green color.
10. The computer-implemented method of claim 8, in, The positive product control is calculated by the processor based on the endotoxin concentration in the PPC minus the endotoxin concentration in the sample and then divided by the actual endotoxin concentration of the 0.5 EU / mL standard.
11. The computer-implemented method of claim 9, in, The positive product control is calculated by the processor based on the endotoxin concentration in the PPC minus the endotoxin concentration in the sample and then divided by the actual endotoxin concentration of the 0.5 EU / mL standard.
12. A system for performing the computer-implemented method according to any one of claims 1-11.
13. A non-transitory computer-readable medium comprising computer-executable instructions, in, When executed, the computer executable instructions cause a processor to perform a computer implemented method according to any one of claims 1-11.
14. A graphical user interface generated according to the computer-implemented method of any one of claims 1-11.
15. A system for testing endotoxins in an injectable pharmaceutical product or water, the system include: processor; as well as a memory having instructions stored on the memory, wherein execution of the instructions by the processor causes the processor to: continuously obtaining one or more data sets associated with measurement results of the multiwell microplate during acquisition of the measurement results of the multiwell microplate, wherein each measurement result is associated with i) a measured level of endotoxin in an acquired sample of an injectable drug product or water over time and ii) an endotoxin reaction of one or more test agents, and wherein the data sets include a current measured level of endotoxin reaction for each well of the multiwell microplate, wherein the multiwell microplate includes at least 96 wells; and in a pane of a graphical user interface, exclusively displaying a side-by-side graphic including a plurality of visual elements based on the acquired data set, wherein each visual element of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate, wherein each of the plurality of visual elements comprises a vertically oriented bar configured to display a data value spanning a range between a minimum value and a maximum value, wherein each of the minimum value and the maximum value is aligned with a respective first horizontal line and a second horizontal line, wherein the graphical user interface further comprises a visual element comprising a third horizontal line at a value indicating a starting threshold of an endotoxin reaction in each well or well group of the at least 96 wells of the multi-well microplate, and wherein the side-by-side pattern of the at least 96 wells of the multiwell microplate provides a simultaneous comparison of the progression of an endotoxin reaction in the at least 96 wells or groups of wells of the multiwell microplate to test for endotoxin in an acquired sample of an injectable pharmaceutical product or water.
16. The system according to claim 15, in, The side-by-side graphic of the at least 96 wells of the multi-well microplate provides an indication of incorrectly configured wells, and wherein the indication is used to retest the sample of injectable drug product or water in the incorrectly configured wells in a subsequent test or to evaluate the retesting of the sample.
17. The system according to claim 15, in, The one or more data sets associated with the measurement results of the multi-well microplate having the at least 96 wells are continuously acquired and displayed at predetermined intervals of at least once a second, wherein the intervals are fixed to provide an observation of the rate of endotoxin reaction in the at least 96 wells or a portion of the at least 96 wells.
18. The system according to claim 16, in, The one or more data sets associated with the measurement results of the multi-well microplate having the at least 96 wells are continuously acquired and displayed at predetermined intervals of at least once a second, wherein the intervals are fixed to provide an observation of the rate of endotoxin reaction in the at least 96 wells or a portion of the at least 96 wells.
19. The system according to any one of claims 15 to 18, in, The instructions, when executed by the processor, cause the processor to: receiving input from an input device, wherein the input is associated with a cursor of the graphical user interface; determining, in the pane of the graphical user interface, that the cursor is placed over one of the plurality of visual elements for at least one selection of the group consisting of selections of visual elements or that the cursor is placed over one of the plurality of visual elements for a predetermined period of time; and Displayed in the pane or the second pane of the graphical user interface is i) a graph of measured levels of endotoxin response over time for the one or more wells where the cursor is placed or ii) a measurement parameter associated with the one or more wells where the cursor is placed.
20. The system according to claim 19, in, A graph of the measured level of endotoxin response over time is presented, and wherein, The graph of the measured level of endotoxin response over time includes one or more kinetic curves for selected wells over a reaction time.
21. The system according to any one of claims 15-18 and 20, further comprising: include: The graphical user interface has a horizontal pixel element greater than twice the number of wells of the multi-well microplate.
22. The system according to any one of claims 15 to 18 and 20, in, The graphical user interface has a set of vertical pixel elements, and wherein each of the plurality of visual elements spans at least 80% of the set of vertical pixel elements.
23. The system according to any one of claims 15 to 18 and 20, in, A portion of the at least 96 wells of the multi-well microplate includes a group of one or more standard wells, the group of one or more standard wells including a first standard well and a second standard well, wherein the visual elements associated with the first standard well and the second standard well have a different color than the remaining portion of the at least 96 wells of the multi-well microplate.
24. The system according to any one of claims 15-18 and 20, further comprising: include: A sensor system configured to interrogate the at least 96 wells of the multiwell microplate for a measurement of a measured level of an endotoxin reaction in the multiwell microplate, wherein the sensor system comprises one or more sensors selected from the group consisting of an absorbance sensor, a fluorescence sensor, and a luminescence sensor.
25. The system according to claim 24, in, The sensor system is configured in a 96-well microplate.
26. The system according to claim 24, in, The sensor system is configured with a 104-well microplate.
27. The system according to any one of claims 15-18, 20 and 25-26, in, The measured level of endotoxin reaction comprises a value associated with a measured change in clarity of the obtained sample of the injectable drug product or water associated with a reaction of the one or more test agents.
28. The system according to any one of claims 15-18, 20 and 25-26, in, The measured level comprises a value associated with a measured change in an optical property of the obtained sample of the injectable drug product or water associated with a reaction with the one or more test reagents, the optical property being selected from the group consisting of absorbance, brightness, fluorescence, and a combination of the absorbance, brightness, and fluorescence.
29. The system according to any one of claims 15-18, 20 and 25-26, in, The plurality of visual elements include a first group of visual elements associated with a standard aperture, a second group of visual elements associated with a standard aperture, a third group of visual elements associated with a standard aperture, a fourth group of visual elements associated with a standard aperture, a fifth group of visual elements associated with a standard aperture, and a sixth group of visual elements associated with a standard aperture, wherein the first set of visual elements has a 50-EU / ml standard, wherein the second set of visual elements has a 5-EU / ml standard, Wherein, the third group of visual elements has a 0.5-EU / ml standard, Wherein, the fourth group of visual elements has a 0.05-EU / ml standard, wherein the fifth set of visual elements has a 0.005-EU / ml standard, and Wherein, the sixth group of visual elements has a negative control standard.
30. The system according to any one of claims 15-18, 20 and 25-26, in, The value indicating the starting threshold is user selectable.
31. The system according to any one of claims 15-18, 20 and 25-26, in, The instructions, when executed by the processor, cause the processor to: receiving input from an input device, wherein the input is associated with selection of a measurement parameter for the multiwell microplate, the measurement parameter being selected from the group consisting of: a measured start time, a measured endotoxin concentration, a measured positive product control (PPC) recovery, and a determined matrix effect; obtaining one or more second data sets associated with the selected parameters; and In the pane or the second pane of the graphical user interface, a second plurality of visual elements associated with the selected parameter are displayed, wherein the second plurality of visual elements have a quantity corresponding to the at least 96 wells or a portion of the at least 96 wells.
32. A method for monitoring the testing of endotoxins in an injectable pharmaceutical product or water, said method include: obtaining, by a processor, one or more data sets associated with measurements of a multi-well microplate, wherein each measurement is associated with a measured level of endotoxin in a captured sample of an injectable drug product or water over time, wherein the data sets include a current measured level for each well of the multi-well microplate, wherein the multi-well microplate includes at least 96 wells; and displaying, by the processor, in a pane of a graphical user interface, a side-by-side graphic comprising a plurality of visual elements exclusively based on the acquired data set, wherein each of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate, wherein each of the plurality of visual elements comprises a vertically oriented bar configured to span data values ranging between a minimum value and a maximum value, wherein each of the minimum value and the maximum value coincides with a first horizontal line and a second horizontal line, wherein the graphical user interface further comprises a visual element comprising a third horizontal line at a measured value indicating a starting threshold for each of the at least 96 wells of the multi-well microplate, and wherein the side-by-side pattern of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the rates of reactions in the at least 96 wells or groups of wells of the multi-well microplate to monitor testing for endotoxins in acquired samples of injectable pharmaceutical products or water.
33. The method according to claim 32, further comprising: include: For acquiring the measured level of endotoxin reaction in the multiwell microplate, the at least 96 wells of the multiwell microplate are interrogated by a sensor system, wherein the sensor system includes one or more sensors selected from the group consisting of absorbance sensors, fluorescence sensors and luminescence sensors.
34. A non-transitory computer-readable medium having instructions stored thereon, wherein execution of the instructions by a processor causes the processor to: obtaining one or more data sets associated with measurements of the multi-well microplate, in, Each measurement result is associated with a measured level of endotoxin in a sample obtained of an injectable drug product or water over time, wherein the data set includes the current measured level for each well of the multi-well microplate, wherein the multi-well microplate includes at least 96 wells; and in a pane of a graphical user interface, exclusively displaying a side-by-side graphic including a plurality of visual elements based on the acquired data set, wherein each visual element of the plurality of visual elements is associated with a current measured level for each of the at least 96 wells of the multi-well microplate, wherein each of the plurality of visual elements comprises a vertically oriented bar configured to span data values ranging between a minimum value and a maximum value, wherein each of the minimum value and the maximum value coincides with a first horizontal line and a second horizontal line, wherein the graphical user interface further comprises a visual element comprising a third horizontal line at a measured value indicating a starting threshold for each of the at least 96 wells of the multi-well microplate, and wherein the side-by-side pattern of the at least 96 wells of the multi-well microplate provides a simultaneous comparison of the rates of reactions in the at least 96 wells or groups of wells of the multi-well microplate to monitor testing for endotoxins in acquired samples of injectable pharmaceutical products or water.
35. The non-transitory computer readable medium of claim 34, in, The instructions, when executed by the processor, further cause the processor to: controlling a sensor system configured to interrogate and acquire measurement results of the at least 96 wells of the multiwell microplate with respect to the measured level of endotoxin reaction in the multiwell microplate, wherein the sensor system comprises one or more sensors selected from the group consisting of absorbance sensors, fluorescence sensors, and luminescence sensors.
